<SEC-DOCUMENT>0001193125-22-142285.txt : 20220506
<SEC-HEADER>0001193125-22-142285.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220505160618
ACCESSION NUMBER:		0001193125-22-142285
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220505
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220505
DATE AS OF CHANGE:		20220505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Calyxt, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		22896171

	BUSINESS ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
		BUSINESS PHONE:		(651) 683-2807

	MAIL ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d340284d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clxt="http://www.calyxt.com/20220505" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-05-05_to_2022-05-05">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-05-05_to_2022-05-05">0001705843</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="clxt-20220505.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-05-05_to_2022-05-05"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-05-05</xbrli:startDate> <xbrli:endDate>2022-05-05</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-05-05_to_2022-05-05">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report: (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt:datemonthdayyearen">May&#160;5, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-05-05_to_2022-05-05">Calyxt, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-05-05_to_2022-05-05">001-38161</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-05-05_to_2022-05-05">27-1967997</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-05-05_to_2022-05-05">2800 Mount Ridge Road</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-05-05_to_2022-05-05">Roseville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-05-05_to_2022-05-05">MN</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-05-05_to_2022-05-05">55113-1127</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address and zip code of principal executive offices)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-05-05_to_2022-05-05">(651)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-05-05_to_2022-05-05">683-2807</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-05-05_to_2022-05-05">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-05-05_to_2022-05-05">CLXT</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:exchnameen">The NASDAQ Global Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter). Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2022-05-05_to_2022-05-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;5, 2022, Calyxt, Inc. (the &#8220;Company&#8221;) announced its financial results for the quarter ended March&#160;31, 2022. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 2.02 of this Form <span style="white-space:nowrap">8-K</span> (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered &#8220;filed&#8221; or incorporated by reference therein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d340284dex991.htm">Press Release of Calyxt, Inc. dated May&#160;5, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, Calyxt, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May&#160;5, 2022</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">CALYXT, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael A. Carr</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Michael A. Carr</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">President and Chief Executive Officer</td></tr>
</table></div>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d340284dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL DRAFT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calyxt Reports First Quarter 2022 Financial Results </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Achieved technical BioFactory<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and AIML milestones to support customer
demand-driven molecule development at scale </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Progressed relationships with an expanding network of potential new customers across
the cosmeceutical and flavor and fragrance end markets </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Continued investment in key hires to strategically position Company for
future growth and scale </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Management to host conference call and webcast today at 4:30 p.m. ET </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roseville, MN &#150; May</B><B></B><B>&nbsp;5, 2022 &#150;</B> <U>Calyxt, Inc.</U> (Nasdaq: CLXT), a plant-based synthetic biology company, today announced
financial results for its first quarter ended March&nbsp;31, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The first quarter of 2022 marked a period of instrumental advancement across
several critical areas for Calyxt. As a result of our expanded customer engagement, the breadth and depth of our business development discussions have grown, demonstrated by the 28 molecules identified by potential customers that we have evaluated
for development with our PlantSpring platform for production in our BioFactory. That amount does not include another 58 such molecules that did not meet our criteria and were not evaluated further. Impressively, some of these 28 molecules were
identified by the potential customers as having been unsuccessfully attempted by others in the industry. Simultaneously, we have made significant technical advancements for our PlantSpring and BioFactory platforms. These include the incorporation of
AIML into our bioreactor&#146;s lab scale production process and the completion of the development of a compound identified by a potential customer for evaluation. As this compound&#146;s production scales in the BioFactory, it is expected to lead
to future development and manufacturing contracts from customers. We have also aggressively pursued the expansion of our intellectual property portfolio with multiple patents issued and new patent applications filed during the quarter. This enables
us to carve out space for Calyxt&#146;s proprietary technology including our Plant Cell Matrix<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> (PCM<SUP STYLE="font-size:85%; vertical-align:top">TM) </SUP>and multi-cellular approach that is
foundational for the success of our Company. Finally, in the first quarter we completed an underwritten offering of common stock and warrants that generated approximately $10&nbsp;million in net proceeds. This strengthened our balance sheet and
provides us with the runway to continuing scaling our technology to potentially secure new business arrangements,&#148; said Michael A. Carr, President and Chief Executive Officer at Calyxt. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Carr added: &#147;We have strengthened our position to harness the incredible diversity of plants
and the world&#146;s demand for sustainable products. By leveraging our proprietary PlantSpring technology platform with our BioFactory production system to develop and sell high value plant-based chemistries to potential customers in our large and
innovative target end markets, including cosmeceuticals, nutraceuticals, and pharmaceuticals, we continue our focused drive to realize value for our stakeholders.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key accomplishments in the first quarter of 2022, and through the date of this press release, include the following: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Achievement of Technical PlantSpring<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and
BioFactory<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Milestones </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In January 2022, Calyxt announced that its initial pilot
BioFactory<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> production system became operational at its headquarters in Minnesota. This development occurred on schedule and marked an important first step toward achieving <FONT
STYLE="white-space:nowrap">at-scale</FONT> commercial production. The Company has completed multiple runs in its pilot BioFactory, focusing on ensuring the system is operating as planned, its PCM structures perform as expected, and that data is
being captured properly as it is a driver of future artificial intelligence and machine learning capability (AIML) capability. The pilot facility is modular and designed to be able to continuously produce plant-based chemistries while also producing
multiple compounds at once. These capabilities are expected to provide the Company with flexibility when producing chemistries for multiple customers at the same time. The Company intends to scale this pilot production to enable full production runs
of compounds similar to those demanded for commercial production. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Calyxt has also begun to deploy additional AIML capabilities to both PlantSpring and the pilot Biofactory. Calyxt
currently uses AIML to assist in the identification of gene targets in the PlantSpring development process. During the past quarter it integrated AIML capabilities into its <FONT STYLE="white-space:nowrap">lab-scale</FONT> reactors, enabling the
continual capture and analysis of data, leading to optimization of performance. The Company intends to advance these <FONT STYLE="white-space:nowrap">lab-scale</FONT> AIML capabilities into its pilot-scale reactor later this year. This deployment
drives future decisions and improves test cycles with the goal of shortening development timelines. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Late last year, Calyxt reported considerable progress in discovery and development of sustainable plant-based
molecules in its BioFactory. Results from its metabolomics analyses indicated more than 15,000 chemical signatures, including both known and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">as-yet-uncharacterized</FONT></FONT>
molecules and building block precursors. These signatures are chemical compounds involved in chemical reactions that produce other compounds. The chemical signatures that have been identified form a baseline library that enables Calyxt to quickly
identify and assess customers&#146; targets with the potential to drive accelerated development timelines. From this library, Calyxt has, based on interest expressed by </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
potential customers, produced rosemarinic acid, a compound with antioxidant, anti-inflammatory, and antimicrobial properties and that is used broadly in cosmeceuticals and nutraceuticals. Calyxt
has also used this baseline library to identify six additional compounds of interest for prospective customers. Calyxt intends to move the PCM producing rosemarinic acid into the pilot BioFactory to further advance the BioFactory&#146;s capabilities
and scale. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Using data it has accumulated from its land-based activities and its lab scale bioreactors, Calyxt has
demonstrated at least a <FONT STYLE="white-space:nowrap">35-fold</FONT> increase in yield from land-based production to a lab scale bioreactor. Calyxt projects a further yield increase as it moves production to pilot scale. Taken together with the
land-based to lab results, the further advancement to lab scale could drive an aggregate increase in yield of as much as <FONT STYLE="white-space:nowrap">130-fold</FONT> over land-based production yields based on the current scale of the pilot
BioFactory. These results underpin the Company&#146;s scalability and sustainability benefits of the BioFactory production system. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As part of Calyxt&#146;s ongoing validation of its platform technology, it is on track to realize certain
upcoming technical milestone targets: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Within PlantSpring, and building on Calyxt&#146;s current gene targeting capability, to establish AIML
capabilities for the identification of pathways in the Design phase of development by <FONT STYLE="white-space:nowrap">mid-year</FONT> 2022. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Building on our <FONT STYLE="white-space:nowrap">lab-scale</FONT> reactor AIML rollout, to have AIML capabilities
fully functioning within the pilot BioFactory by <FONT STYLE="white-space:nowrap">mid-year</FONT> 2022. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By the end of 2022, to design additional PCM structures capable of providing the foundational precursors to
developing chemistries and molecules that are of interest to a broad range of customers within our target <FONT STYLE="white-space:nowrap">end-markets.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To advance current engagement with potential infrastructure partners in order to have one engaged by the end of
2022. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Steadfast Focus on Customer Relationships </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Calyxt&#146;s business model for its proprietary PlantSpring technology and the BioFactory is customer
demand-driven. During the quarter the Company continued to advance its discussions with potential customers within its target end markets including the cosmeceutical, including personal care and flavors and fragrances, nutraceutical, and
pharmaceutical industries. These are three key large end markets with customers that have current business needs to source finite plant-based chemistries. They are also markets known to be fast adopters of innovation that are actively seeking to
reduce carbon footprints. For example, based on research from MarketsandMarkets<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>, Calyxt estimates that the cosmeceutical ingredients
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
market, which also includes personal care and flavors and fragrances, was a spend of more than $60 billion in 2020 and growing at a mid-single digit compound annual growth rate. This market
includes large multinational cosmetics brands, regional and specialty brands, and flavor and fragrance houses who manufacture products or provide ingredients for those brands. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Source: (i)&nbsp;MarketsandMarkets, Personal Care Ingredients Market &#150; Global Forecast to 2025, (ii)
MarketsandMarkets, Global Color Cosmetics Market &#150; Forecast Till 2020, (iii) MarketsandMarkets, Fragrance Ingredients Market&nbsp;&#150; Global Trends&nbsp;&amp; Forecast to 2019, and (iv)&nbsp;MarketsandMarkets, Flavors and Fragrance Market
&#150; Global Forecast to 2026 </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The breadth and depth of Calyxt&#146;s business development discussions have grown. Calyxt has evaluated 28
molecules identified by potential customers for development with PlantSpring for production in our BioFactory. That amount does not include another 58 such molecules that did not meet Calyxt&#146;s target product profile, or TPP, criteria and were
not evaluated further. The group of 28 molecules includes several that were identified by the potential customers as having been unsuccessfully attempted by others in the industry. As part of the customer acquisition process, Calyxt is expecting to
produce small quantities of product for evaluation by the customer and as a result, Calyxt believes the development cycle from contract signing to commercialization may likely be shorter than 36 months. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company is targeting two to four customer demand-driven compounds for development by year end using its
selection criteria to determine the compounds to pursue. The Company uses the term &#147;compounds&#148; to describe compounds, molecules, and plant-based chemistries interchangeably. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;In our conversations with customers, it&#146;s exciting to see their recognition of the advantages in our approach,&#148; said Michael A. Carr.
&#147;They understand that our innovative technology platform and cutting-edge production system can provide sustainable biomanufacturing solutions to meet their product and ingredient needs.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Calyxt&#146;s business model for PlantSpring and BioFactory has two customer demand-driven revenue streams, one focused on development activity and the other
on product sales. Most important is the product revenue expected to be generated once commercialization is achieved. Calyxt anticipates a rapid revenue ramp following the customers&#146; commercial launch of a compound, and is targeting
customers&#146; compounds with large demand pools, potential multi-million-dollar annual revenue opportunities per compound, and a target gross profit margin in the <FONT STYLE="white-space:nowrap">mid-double</FONT> digits at scale. Calyxt also
believes its prospective customers will pay for development in some instances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Licensing of Technology and Traits </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the first quarter of 2022, Calyxt finalized its strategy for optimizing potential revenue from the licensing
of its technology and plant traits. The strategy is <FONT STYLE="white-space:nowrap">two-pronged</FONT> and reflects (1)&nbsp;a broad outreach to companies in the plant gene-editing and biotechnology space for their licensing of the Company&#146;s
intellectual property assets and (2)&nbsp;the monetization of the Company&#146;s historically developed agricultural traits through their license to counterparties including seed companies, processors, and others. Calyxt is offering licenses for the
many gene editing and breeding technologies in its patent portfolio, including its TALEN patent estate. As it relates to the licensing of agricultural traits strategy, active discussions are occurring on multiple traits, including Calyxt&#146;s
soybean and wheat offerings. Calyxt is targeting the execution of licenses in both the technology and trait licensing categories during 2022.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the fourth quarter of 2021, Calyxt contracted with a large food ingredient manufacturer to develop a soybean
intended to produce an oil that could serve as a replacement for palm oil. The project remains on track for a first quarter of 2024 completion. The food ingredient manufacturer is funding Calyxt&#146;s development costs over the term of the
agreement and holds an option for future development and commercialization. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investments in Key Hires </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February 2022, Calyxt announced that Gerry Nuovo joined the Company as Senior Vice President of Business
Development, bringing more than 30 years of experience in the specialty chemicals and biotechnology industries and diverse experience building multimillion-dollar income streams in the cosmeceuticals end market, including personal care and home
care. Mr.&nbsp;Nuovo will be responsible for business development activities in cosmeceuticals, including potential partnerships, deal structures, valuation models, and subsequent transaction execution and alliance management. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In April 2022, the Company announced the hires of Ms.&nbsp;Suellen Boot as Business Development Director and
Ms.&nbsp;Elizabeth Teigland as Manufacturing Director. Ms.&nbsp;Boot brings over 20 years of valuable business development experience to Calyxt where she will be responsible for a number of functions, including potential partnerships, deal
structures, valuation models, and subsequent transaction execution and alliance management. Ms.&nbsp;Teigland brings over 15 years of chemistry and purification expertise to Calyxt and will be responsible for pilot to commercial scale production of
the Company&#146;s customer demand-driven compounds, and along with an R&amp;D leader, the Verify stage of product development. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Business Updates </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February 2022, Calyxt closed the placement to an institutional investor in an
<FONT STYLE="white-space:nowrap">SEC-registered</FONT> underwritten offering of 3,880,000 shares of its common stock, <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants to purchase up to 3,880,000 shares of its common stock, and common
warrants to purchase up to 7,760,000 shares of its common stock. The gross proceeds of the offering were $10.9&nbsp;million, before deducting underwriting fees and estimated offering expenses.&nbsp;The Company plans to use the approximately
$10.0&nbsp;million in net proceeds from the offering for enhancing the capabilities of its BioFactory production system and increasing its capacity to produce at larger scales, continuing to build out the Company&#146;s PlantSpring technology
platform and AIML capabilities, furthering customer relationships, and for working capital and general corporate purposes. The pre-funded warrants were exercised in full on May 4, 2022. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Results for the Three Months Ended March&nbsp;31, 2022 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cash, cash equivalents, and restricted cash totaled $17.9&nbsp;million as of March&nbsp;31, 2022, including net
proceeds of $10.0&nbsp;million that was raised in <FONT STYLE="white-space:nowrap">mid-February</FONT> from the <FONT STYLE="white-space:nowrap">SEC-registered</FONT> offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Revenue was nominal in the first quarter of 2022 compared to $4.4&nbsp;million in the first quarter of 2021. The
decrease in revenue was driven by the late 2021 completion of the wind-down of the Company&#146;s soybean product line. All revenue in the first quarter of 2022 was associated with the Company&#146;s agreement with a food ingredient manufacturer to
develop a palm oil alternative. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total operating expenses were $6.1&nbsp;million in the first quarter of 2022 compared to $7.3&nbsp;million in the
first quarter of 2021. The decrease was primarily driven by the recapture of <FONT STYLE="white-space:nowrap">non-cash</FONT> stock compensation expense from the forfeiture of unvested stock awards in the first quarter of 2022 and lower operating
expenses. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Net loss was $5.6&nbsp;million in the first quarter of 2022 compared to $10.0&nbsp;million in the first quarter
of 2021. The improvement in net loss was driven by the completion of the wind-down of the soybean product line which drove an improvement in gross margin and lower operating expenses. Net loss per share was $0.13 in the first quarter of 2022
compared to $0.27 in the first quarter of 2021. The improvement in net loss per share was driven by the improvement in net loss and a year-over-year increase in weighted average shares outstanding. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adjusted net loss was $6.0&nbsp;million in the first quarter of 2022 compared to $8.8&nbsp;million in the first
quarter of 2021. The improvement in adjusted net loss was driven by the completion of the wind-down of the soybean product line which drove an improvement </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
in gross margin and lower operating expenses. Adjusted net loss per share was $0.14 in the first quarter of 2022 compared to $0.24 in the first quarter of 2021. The improvement in adjusted net
loss per share was driven by the improvement in adjusted net loss and a year-over-year increase in weighted average shares outstanding. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The continued expansion of our AIML capabilities has already contributed to expediting the development process, and we believe we can now complete the
Design, Engineer, and Verify phases of our development cycle in some cases in as little as nine months&#146; time and we look forward to reporting progress against the <FONT STYLE="white-space:nowrap">24-month</FONT> pilot cycle in the future. In
addition, we have now secured key hires that represent our revenue streams: business development, chemistry/purification, and licensing,&#148; said Bill Koschak, Chief Financial Officer at Calyxt. &#147;Further, the approximate $10.0&nbsp;million in
net proceeds from the capital raise we recently completed in February, in spite of volatile market conditions, allows us to scale our BioFactory production and AIML capabilities. Our plans to utilize PlantSpring and the BioFactory to target
customers in large and innovative end markets like cosmeceuticals, nutraceuticals, and pharmaceuticals are resonating in conversations across industries, and we look forward to providing updates in the coming months. Thanks to the successful
offering of our common stock and warrants and assessing our discretionary spending, we now expect Calyxt&#146;s cash runway to extend into early 2023.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>First Quarter 2022 Results Conference Call </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Calyxt&#146;s
President and Chief Executive Officer, Michael A. Carr, and Chief Financial Officer, Bill Koschak, will host a conference call discussing Calyxt&#146;s results for the first quarter of 2022, followed by a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">question-and-answer</FONT></FONT> session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of Calyxt&#146;s website at
<U>www.calyxt.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To access the call, please use the following information: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Thursday, May&nbsp;5, 2022</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Time:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4:30 p.m. EST, 1:30 p.m. PST</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Toll Free <FONT STYLE="white-space:nowrap">dial-in</FONT> number:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-888-317-6003</FONT></FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Toll/International <FONT STYLE="white-space:nowrap">dial-in&nbsp;number:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-412-317-6061</FONT></FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Conference ID:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2452642</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please call the conference telephone number <FONT STYLE="white-space:nowrap">5-10</FONT> minutes prior to the start time. An
operator will register your name and organization. The conference call will also be broadcast live and available for replay via the investor relations section of the company&#146;s website at <U>www.calyxt.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A replay of the webcast will be available for 30 days following the event. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Toll Free Replay Number:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-877-344-7529</FONT></FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">International Replay Number:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-412-317-0088</FONT></FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Replay ID:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9265408</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About the PlantSpring<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Technology Platform and BioFactory<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Production System </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Calyxt&#146;s technology platform, PlantSpring, is founded on the
Company&#146;s more than a decade of experience engineering plant metabolism, and incorporates its scientific knowledge, its proprietary systems, tools, and technologies; and an expanding set of AIML capabilities. In PlantSpring, the Company
identifies metabolic pathways to produce plant-based chemistries, designs strategies to reprogram host cells, engineers plant cell metabolism to optimally produce targeted compounds, and produces those targeted compounds at laboratory scale. The
Company has implemented AIML capabilities for the identification of targets for editing specific genetic pathways and continues to develop AIML capabilities across the PlantSpring platform, which will enable learning and adaptation of knowledge
gained from past activity and are expected to be combined with predictive analytics to rapidly prototype and provide feedback, accelerate the time to complete the development cycle and help mitigate the risk associated with commercial <FONT
STYLE="white-space:nowrap">scale-up.</FONT> As a result, Calyxt believes it can develop biomolecules in plants for customers at both a greater breadth and level of complexity and at faster speeds than its competitors in the synthetic biology
industry. The output from the PlantSpring platform integrates with the Company&#146;s BioFactory production system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The BioFactory is a bioreactor-based
production system that is designed to be capable of continuous production of plant-based chemistries. The bioreactor can be of any size depending upon factors including yield and titer necessary to reach the required commercial scale. For
production, multicellular Plant Cell Matrix<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>(PCM<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>) structures are placed inside
the bioreactor, and growth media bathes the PCM structures to provide them with nutrition, which differentiates the Company&#146;s process from other methods that require complete submersion of cells in growth media and/or the application of
hormones to facilitate growth. A PCM structure is a living system of various cell types, which is designed to emulate the intercellular metabolism of an entire plant, which grows over time, produces, and stores, or excretes, the target chemistries.
The growth media is the feedstock of the BioFactory production system and contains the essential inputs to support growth of the PCM structures and necessary chemistry production. The growth media is expected to be reused throughout the production
cycle, which may run for an extended time period. To scale production in the BioFactory productions system, the Company expects to move the PCM structures from its current bioreactor into larger capacity bioreactors or groups of bioreactors. Calyxt
began running <FONT STYLE="white-space:nowrap">lab-scale</FONT> bioreactors in early 2021. The Company&#146;s first pilot-scale bioreactor became operational in December 2021 and is scalable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
up to 200 liters. The pilot stage of development takes a compound developed with the PlantSpring platform through to commercial production. Depending on the compound to be produced, there may be
a range of vessel sizes between the initial pilot facility and the commercial production facility. The Company&#146;s current plan is to engage third parties, referred to as infrastructure partners, for
<FONT STYLE="white-space:nowrap">at-scale</FONT> commercial production. Infrastructure partners are likely to be companies with processing assets that can be converted from current production to the Company&#146;s bioreactor-based approach. If an
infrastructure partner is used for production, the Company expects to pay a fee for that production. Because of the expected modular nature of the BioFactory production system and the types of high value compounds the Company expects to develop for
customers, it is also possible that commercial production could also occur in a customer&#146;s <FONT STYLE="white-space:nowrap">in-house</FONT> facility. The Company expects to expand the scope of its pilot facilities based on customer demand, and
the scope of production could extend, subject to regulatory and other considerations, outside the United States. Because of its production methodology, Calyxt believes the BioFactory has the potential to be one of the most sustainable production
systems across industries<B>. </B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Calyxt </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers&#146; materials and products. As plant-based solutions, the
Company&#146;s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt&#146;s diversified offerings are primarily delivered through its proprietary BioFactory<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> production system. For more information, visit www.calyxt.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PlantSpring, BioFactory, Plant Cell
Matrix<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Calyxt Media Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>Calyxt Investor Relations Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Rosen/ John Garabo/ Michael Barron</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Argot
Partners</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212) <FONT STYLE="white-space:nowrap">600-1902</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>media@calyxt.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kimberly Minarovich/ Cameron Willis</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Argot Partners</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212)
<FONT STYLE="white-space:nowrap">600-1902</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>investors@calyxt.com</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Calyxt Business Development Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gerry Nuovo</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President of Business
Development</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(612) <FONT STYLE="white-space:nowrap">427-7881</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>contact@calyxt.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>USE OF <FONT STYLE="white-space:nowrap">NON-GAAP</FONT> FINANCIAL INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To supplement the Company&#146;s financial results prepared in accordance with GAAP, it has prepared certain <FONT STYLE="white-space:nowrap">non-GAAP</FONT>
measures that include or exclude special items. These <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures are not meant to be considered in isolation or as a substitute for financial information presented in accordance with GAAP and should be
viewed as supplemental and in addition to the Company&#146;s financial information presented in accordance with GAAP. Investors are cautioned that there are material limitations associated with the use of
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures. In addition, other companies may report similarly titled measures, but calculate them differently, which reduces their usefulness as a comparative measure. Management utilizes
these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> metrics as performance measures in evaluating and making operational decisions regarding the Company&#146;s business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s 2021 <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures reflect adjustments for certain commodity derivatives entered into
in connection with its soybean product line. As a result of the completed wind-down of this product line, the Company held no commodity derivative contracts as of March&nbsp;31, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company presents adjusted net loss, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure, and defines it as net loss including adjustments necessary
to present the underlying gross profit of its soybean product line, including (i)&nbsp;unrealized gains and losses associated with commodity derivatives entered into to hedge the change in value of fixed price grain inventories and fixed price grain
production agreements that should be recognized in the future when the underlying inventory is sold, (ii)&nbsp;gains and losses from commodity derivatives realized in prior periods but associated with inventory sold in the current period,
(iii)&nbsp;net realizable value adjustments to inventories occurring in the period which otherwise would have been recognized in the future when the underlying inventory is sold, and (iv)&nbsp;net realizable value adjustments recognized in prior
periods but associated with inventory sold in the current period, and excluding cash-based Section&nbsp;16 officer transition expenses, the recapture of <FONT STYLE="white-space:nowrap">non-cash</FONT> stock compensation associated with the
departure of Section&nbsp;16 officers, and <FONT STYLE="white-space:nowrap">non-operating</FONT> expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company provides in the table below a reconciliation of net loss, which is the most directly comparable
GAAP financial measure, to adjusted net loss. The Company provides adjusted net loss because it believes that this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial metric provides investors with useful supplemental information at this
stage of commercialization as the amounts being adjusted affect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparability of net losses and financial performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below presents a reconciliation of net loss to adjusted net loss: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>In Thousands</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss (GAAP measure)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commodity derivative impact, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net realizable value adjustment to inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;16 officer transition expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>116</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recapture of <FONT STYLE="white-space:nowrap">non-cash</FONT> stock compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-operating</FONT> expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,990</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(8,848</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company presents adjusted net loss per share, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure, and defines it
as net loss per share including adjustments necessary to present the underlying gross profit of its soybean product line, including (i)&nbsp;unrealized gains and losses associated with commodity derivatives entered into to hedge the change in value
of fixed price grain inventories and fixed price grain production agreements that should be recognized in the future when the underlying inventory is sold, (ii)&nbsp;gains and losses from commodity derivatives realized in prior periods but
associated with inventory sold in the current period, (iii)&nbsp;net realizable value adjustments to inventories occurring in the period which otherwise would have been recognized in the future when the underlying inventory is sold, and
(iv)&nbsp;net realizable value adjustments recognized in prior periods but associated with inventory sold in the current period, and excluding cash-based Section&nbsp;16 officer transition expenses, the recapture of
<FONT STYLE="white-space:nowrap">non-cash</FONT> stock compensation associated with the departure of Section&nbsp;16 officers, and <FONT STYLE="white-space:nowrap">non-operating</FONT> expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company provides in the table below a reconciliation of net loss per share, which is the most directly comparable GAAP financial measure, to adjusted net
loss per share. The Company provides adjusted net loss per share because it believes that this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial metric provides investors with useful supplemental information at this stage of
commercialization as the amounts being adjusted affect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparability of net losses per share and financial performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below presents a reconciliation of net loss per share to adjusted net loss per share: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share (GAAP measure)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commodity derivative impact, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net realizable value adjustment to inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;16 officer transition expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recapture of <FONT STYLE="white-space:nowrap">non-cash</FONT> stock compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.07</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-operating</FONT> expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.01</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted net loss per share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.24</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains &#147;forward-looking statements&#148; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as &#147;anticipates,&#148; &#147;believes,&#148; &#147;continue,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;intends,&#148;
&#147;may,&#148; &#147;might,&#148; &#147;plans,&#148; &#147;predicts,&#148; &#147;projects,&#148; &#147;should,&#148; &#147;targets,&#148; &#147;will,&#148; or the negative of these terms and other similar terminology. Forward-looking statements in
this report include statements about the Company&#146;s future financial performance, including its cash runway; its product pipeline and development; its business model and strategies for the development, commercialization and sales of commercial
products; commercial demand for its synthetic biology solutions; the development and deployment of its PlantSpring technology platform; its ability to deploy and leverage its artificial intelligence and machine learning (AIML) capabilities; the
ability to scale production capability for its BioFactory production system; potential development agreements, partnerships, customer relationships, and licensing arrangements and their contribution to its financial results, cash usage, and growth
strategies; the potential impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on its business and operating results; and anticipated trends in its business. These and other forward-looking statements are predictions and
projections about future events and trends based on the Company&#146;s current expectations, objectives, and intentions and are premised on current assumptions. The Company&#146;s actual results, level of activity, performance, or achievements could
be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: the impact of increased competition, including competition from a broader array of
synthetic biology companies; competition for customers, partners, and licensees and the successful execution of development and licensing agreements; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disruptions at its key facilities, including disruptions impacting its BioFactory production system; flaws in AIML algorithms, insufficiency of data inputs required by such algorithms, and human
error in interacting with AIML; changes in customer preferences and market acceptance of its products; changes in market consensus as to what attributes are required for a product to be considered &#147;sustainable&#148;; the impact of adverse
events during development, including unsuccessful pilot production of plant-based chemistries or field trials; the impact of improper handling of its product candidates during development; failures by third-party contractors; inaccurate demand
forecasting or milestone and royalty payment projections; the effectiveness of commercialization efforts by commercial partners or licensees; disruptions to supply chains, including raw material inputs for its BioFactory; the impact of changes or
increases in oversight and regulation; disputes or challenges regarding intellectual property; proliferation and continuous evolution of new technologies; management changes; dislocations in the capital markets; the severity and duration of the
evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and the resulting impact on macro-economic conditions; and other important factors discussed in Part I, Item 1A, &#147;Risk Factors&#148; in the Company&#146;s filings with the SEC,
included in Part I, Item 1A of its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021, which was filed with the SEC on March&nbsp;3, 2022 (its Annual Report) and its subsequent reports on
Forms <FONT STYLE="white-space:nowrap">10-Q</FONT> and <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC. Any forward-looking statements made by management of the Company are based only on currently available information and speak only
as of the date of this report. Except as otherwise required by securities and other applicable laws, the Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new
information, future developments or otherwise, should circumstances change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALYXT, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED BALANCE SHEETS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In Thousands, Except Par Value and Share Amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,<BR>2022</B><br><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B><br><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,285</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>499</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,973</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>99</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Land, buildings, and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,125</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13,973</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>175</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>38,345</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,167</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>379</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,209</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to related parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>64</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion of financing lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>290</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,976</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>435</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,520</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>89</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>13,742</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>73</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23,424</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Stockholders&#146; equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value; 275,000,000 shares authorized; 42,841,915 shares issued and
42,741,763 shares outstanding as of March&nbsp;31, 2022, and 38,874,146 shares issued and 38,773,994 shares outstanding as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>216,838</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock in treasury, at cost; 100,152 shares as of March&nbsp;31, 2022, and
December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,043</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,043</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(200,879</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(196,092</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,921</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities and stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>38,345</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALYXT, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In
Thousands Except Shares and Per Share Amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,343</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,941</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general, and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,180</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Management fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,121</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss from operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,089</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,681</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(17</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-operating</FONT> expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Basic and diluted net loss per share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Weighted average shares outstanding - basic and diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,020,090</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,136,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Anti-dilutive stock options, restricted stock units, and performance stock
units</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16,276,362</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,013,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g340284dsp1p2.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALYXT, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in
Thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,619</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used by operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>370</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>531</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,450</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized (gain) loss on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> of common stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(435</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to/from related parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(108</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(652</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(110</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(145</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>37</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(313</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(612</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash used by operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,404</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and (purchases) of short-term investments, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of land, buildings, and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(545</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash (used by) provided by investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(545</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from the issuance of common stock and pre-funded warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,209</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Costs incurred related to the issuance of common stock and pre-funded warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(704</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayments of financing lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(94</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from the exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,411</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash, cash equivalents, and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,462</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(913</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and restricted cash - beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,421</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash, cash equivalents, and restricted cash&nbsp;&#150; end of period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,883</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>clxt-20220505.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/6/2022 12:01:00 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:clxt="http://www.calyxt.com/20220505"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.calyxt.com/20220505"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clxt-20220505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clxt-20220505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>clxt-20220505_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/6/2022 12:01:00 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>clxt-20220505_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 5/6/2022 12:01:00 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="clxt-20220505.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g340284dsp1p2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g340284dsp1p2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M,9+_ ,EYW^ _[%SC"INA6ORZI4ZC4M/-JE]UWZ%CP5_P4 _:O_9Q\2VW@O\
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MM_>EM'[]DSS\RQ\,OPTJKUF](1[ON_*.[VOI%.\D?$_[%[_$;]I[P-K/C_\
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M&(HQK1C1NE.*:3YXJ]GUL['S_$.)K83"T9T*DJ<G4LW&4HZ<K>\6GT]#W_\
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M]LRQ_:*TWQ-X&M_!]IX]^'OBA](O+G6U\0FP\)6V@PZA"L4.D/:?:I6TN<Q
MW(4ATWLN3A8;/,+0R=Y?*G4]K[*K#F2CRWGSVUYKV7,KZ=PKY-B*N:+'1G!4
MU5I3LY2YK0]G=6Y&K^X[>]U1^KE?+'TA^$7_  6#L?!D'BKX.:G!,4\?W&@^
M([75;>-$V2>#;.]MI=(NKMQAEECUJXU>. 88.LEWDKY*AON>$95O98N+7^SQ
ME%Q?:=O>27^%1OVT[GQO%$*7/AK?QY1LTDOAYO<N]UJZENCL[[(_0+_@GY\%
MO^%,_LW^$TU&T^S>*OB /^%@^)]Z!;B&77+> Z)ILI/S#[%X?BTV-HV^Y/)<
M\#<<^!G^,^N9C5Y7>EA_W4.WNM\S^<KV?9(]S),(L)@*2M:=;]Y+T:]U6Z>[
M9M=).1]>^*&\21^'=;;P?!I,_BH:;=CP]%KUQ<VFB'5VA9;%M5GLK>>=+!)R
MCRB&)G9$95P6##R:7LU4A[9R5)27/RI.7+?7E3:5[;7=CTZGM%3G[)1=1)\B
MDVH\W2]DW9=;'Y0_ 7_@G3X_TGX^/\;?VC?&/A+X@7%MJ=WXPAL=(DU>]?6O
M'=Q=B>SU'6EU73+6*/2].<FY@M8MZ^;;V<>P06Y1_J<=Q#0E@%@LNI3H)I4V
MY**Y::5FH\LI.\EHV^C;O=IGSF#R.K'&O%XVI&K9N22DY7E>ZO>$4DG>3LM7
M9)*+:?ZG>/? OAGXE^#?$?@+QCIT>J^&?%.EW&DZM9/A6:WN%^2:WEP3;WMO
M,L5Q!.OS0S012)AD!KY>A7J86M3KT9<M2DU*+].C75-:-=4VCZ&M1IUZ4Z-5
M<T)JS7Y-/HT[-/HTF?E[^R_^Q!^T1^RY\9Y_%7ASQ[X U_X:ZM<SZ'XGT.[N
M_$%EJ^O>$1=ROI6I/:)HLEG:^*M.#K<1[;AHBSW=L)1#=,P^FS/.LOS+!JE4
MH5:>)@N:$DHN,9VU5^:[A+9Z)[.UTCY_+\HQF78IU*52G*A)VE%RDFXW_EY+
M)KXHKF=G[M[.3?TK^W1^S7XT_:=^''A+P?X(UCPYHVH:#XVA\274_B6;48;2
M2RCT/6=,,,#:;874AN?/U&%L,BKM1_FR #YV1YE1RS$5:M:$Y1G3Y$H)-WYH
MRZN.ED=N<9?5S"A2I4I1BZ<^9\S:TY91Z1EW[?,]<_9;^%.O_!#X#_#_ .%W
MB>]TK4==\)V6J6U_>Z))=2Z7.][K^JZI$UJ][;6\S*MO?1*V^)/G5@,@ GDS
M/%4\;CJ^)I*485'&RE9/2$8ZI-K==SKR_#SP>$I8>;3E3YK\K;6LY26K2V3L
M]%J>_P!<!VA0!XC^T)\"O"?[1/PPUSX;^*P;87@6^T#7(8UDOO#7B2R20Z7K
M=FK$;S$\CQ30%E$]M<7$#,HEW+VY?CJN7XF&(I:\NDH])P>\7]UT^C2>MCDQ
MN#IXW#SH5%:^L96^&25D^FG1JZNFU=;GX5?!OXV?&?\ X)S_ !6UGX4?%7P_
M?ZO\/-2OC>ZGH=M(S6MU"["WA^('PVO[K9!/Y\,<8N;-VB6?R1!<BVO+=7C^
MWQ>"P?$.%ABL+44,1%64NJZNG52U5GL];7O&\7K\AA<7BLAQ$L-B8.6';VO\
ME*,M%LM'HI)<LN5Q_=_8'Q!_8\_9C_;4TZ[^+'[-WC_1?"/BK5!]KUVPTVT2
M?0;K4[C$DJ^+/!9>WO\ PIK3R,PEN+=(TE8&4V]PS^:_DX?-\RR:2PF8T)5:
M4=(N3]Y):+DJ:QG%=$]5MS*UCTZV5Y?FB^L8&LJ53=J.BN[/6*M*#??6.KDH
MMN[^:[3]D+_@I'\(1)HOPW\9:Y/H4+&.V7P3\719:08U/RM!HWB:\T\V8("_
M*MLN.!DXKT7FW#N+]_$48QGU]I0O+YRC&=_O//669[A/=H5)2BM$H5>6*72R
MYZ?_ *2A7_89_;]^-MU;VOQA\<W%GHX=6E?Q]\3+KQ/;6ZJ1EX/#OAZXOX)I
MP -H;R 2 #(H&0+.\AP2;PE!2FEI[*BH/T<I*#M]_H/^R,YQ;7UFJXQNKJ=7
MFM;K&TJMGZ)>I]5^%?A%^R1_P3HTI?'OQ*\5Q>//C$MF[Z(MQ;6<_B,SO'L:
MW\">"X;B4:'%+N,;ZQ?SDJA8->1(YB;RZN+S;B&?L,-2=#!WM*S?);_IY4LN
M:W\D5_VZ[7/1I87+<BA[6M457$Q5TK+FO:UX1N^7?XI2TNTFKV?-? ?X^^,O
MVZ_&OB_0=>\#7?AO0_#UP;_P_P"(=)6XO_#?AW0+J6&+_A'?$EY<,D<OC26-
M6NH+BV55NE6:-H+>*UCDD[J^'PW#V&BXU%4K5%K%V4ZDUU2UM3CU73NY,^3S
M# 9EQ3F.&JTJOL<'2O"49*T*$+WE5I_\_)U+*-I6?,DU:"DH_KCX6\,Z-X-T
M#2_#.@6B66E:1;+;6L*@;C@EY9YF 'F7,TS22R2'EGD9N]?%UJU2O5G5JOFG
M-W;_ "2[)+1+HD?I.$PM'!8:CA</'DHT(J,5UTW;?64G=R?5MLWZR.@* "@
MH * "@ H * "@ H _%#XH_L@?M"?M$?ME1?$+XC^#[;1_@O!XJTNPBGE\4^'
MKRX3X=>$"\UI9II-IJ,US%/KUS!/))$(B8GUZ0R8$38^SPN;X#+\G>'PU;FQ
MC@W90FOWL]W=Q2]RZ6^J@NY\GB,KQF-S-5J])QPRE;5TW^[B[):2<O>BKKW;
MQG-O;4_:U$2)$CC18XXU5$1%"(B( JHBJ %55      KXP^L2MHM$MD.H *
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140141064894472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Calyxt, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2800 Mount Ridge Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Roseville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55113-1127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(651)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-2807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLXT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d340284d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clxt-20220505.xsd" xlink:type="simple"/>
    <context id="duration_2022-05-05_to_2022-05-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2022-05-05</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-05-05_to_2022-05-05">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-05-05_to_2022-05-05"
      id="Hidden_dei_EntityCentralIndexKey">0001705843</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-05-05_to_2022-05-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-05-05_to_2022-05-05">2022-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-05-05_to_2022-05-05">Calyxt, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-05-05_to_2022-05-05">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-05-05_to_2022-05-05">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-05-05_to_2022-05-05">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-05-05_to_2022-05-05">2800 Mount Ridge Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-05-05_to_2022-05-05">Roseville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-05-05_to_2022-05-05">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-05-05_to_2022-05-05">55113-1127</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-05-05_to_2022-05-05">(651)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-05-05_to_2022-05-05">683-2807</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-05-05_to_2022-05-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-05-05_to_2022-05-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-05-05_to_2022-05-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-05-05_to_2022-05-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-05-05_to_2022-05-05">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-05-05_to_2022-05-05">CLXT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-05-05_to_2022-05-05">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-05-05_to_2022-05-05">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2022-05-05_to_2022-05-05">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ R("E5)E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #(@*54EP<C<U,$  #8$   &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ R("E5)^@&_"Q @  X@P   T
M             ( !E@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #(@*54
MEXJ[',     3 @  "P              @ %R#P  7W)E;',O+G)E;'-02P$"
M% ,4    " #(@*54'#AEZC\!   \ @  #P              @ %;$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ R("E5"0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ R("E5&60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d340284d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d340284d8k.htm">d340284d8k.htm</File>
    <File>clxt-20220505.xsd</File>
    <File>clxt-20220505_lab.xml</File>
    <File>clxt-20220505_pre.xml</File>
    <File>d340284dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d340284d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d340284d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clxt-20220505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clxt-20220505_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clxt-20220505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "clxt",
   "nsuri": "http://www.calyxt.com/20220505",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d340284d8k.htm",
      "contextRef": "duration_2022-05-05_to_2022-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d340284d8k.htm",
      "contextRef": "duration_2022-05-05_to_2022-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.calyxt.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-22-142285-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-142285-xbrl.zip
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ML?*<W_2(YE1AO#"9X?+FU!,EL\KB;$:3E4:E2D%U@E:K@=_U@,P5DPIA8TM
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MC/BY'@!'AC484E*_$7AL\!L;YC(D+:BP)FDVZ,ZQ?7A2+LW25YCBC&1=)L&
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M$PW-^K%T%/-V,3\'^61[VU4N\*E (9YFDZG(UPIMUBW8RB35AR>SWH^,84V
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MY,,T\A!$%\9.;CVZDT2HR 4,E=!Q@ @-,)*/^B"ZAL)[%H ]\2>O+A ?!H[
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M-Z=-)J76XZP+CBN]%WYK[H7+>1!HM$DW X3."O$7V\WWW"_^#U!+ P04
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M1'=./TKA%OB*0[BYWF_B""^.DF1S(^U*QXN2GO1D1J0DDMT%XCZ*^:^QZ,3
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M[Q%_A;"35,6.*4U 9:$]NR(5X3X)"D8!HN?C'\</#P\['DML6-W'#W\<*ZB
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M1]$*7%?B:KNN4FDV5XBXBIP+LND.:GN[C4IS#IMN42'&DY9NA;%"T7..>$"
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M1;U@?>Z ^@)E")Q6>[<,X9@+[K$S/!:L+GXR\6]-7WKAPS+?%*>7/KE[,RF
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M&&^WO@8=X5M5MS$3%-#:=D$NCM7^"&%_ <[Q=;8ZP@_?LVJ,0ECTM'ZUJ1?
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M&H,]!WOT3<LZX+@XD^T5POJIKP'43W5OOY1G<W#7:D62M^I+Z5F</Y;<?&.
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M6O;%@/N]@3_OC%H.I$B 95N!W]%#)9?.E@=KD89KEL@#B[$#Y \9>WY"@K,
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M-3 U7VQA8BYX;6Q02P$"% ,4    " #(@*542>Q(5<P$   Y+   %0
M        @ $M"@  8VQX="TR,#(R,#4P-5]P<F4N>&UL4$L! A0#%     @
MR("E5);]7WPV#P  .&$   X              ( !+ \  &0S-# R.#1D.&LN
M:'1M4$L! A0#%     @ R("E5-,P.PD/0P  56L" !$              ( !
KCAX  &0S-# R.#1D97@Y.3$N:'1M4$L%!@     %  4 0 $  ,QA      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
